{"id":"W4308702501","doi":"10.1016/s2213-8587(22)00308-4","title":"Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; Respicardia; Sanofi Pasteur; National Institutes of Health; Daiichi-Sankyo; Moderna; Sarepta Therapeutics; Alnylam Pharmaceuticals; MyoKardia; Gilead Sciences; Cytokinetics; American Regent; Sanofi; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca Korea; GlaxoSmithKline; Celladon Corporation; Amgen","keywords":"Medicine; Heart failure; Ejection fraction; Dapagliflozin; Internal medicine; Atrial fibrillation; Placebo; Cardiology; Prediabetes; Type 2 diabetes; Adverse effect; Diabetes mellitus; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002708477,0.001913081,0.006162418,0.0006438688,0.0003713373,0.001637506,0.0008034583,0.001618248,0.003174635],"category_scores_gemma":[0.003070716,0.0006618385,0.007563928,0.000581252,0.0006184911,0.001039596,0.0006854832,0.002252934,0.000466938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006894328,"about_ca_system_score_gemma":0.0006263619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001090144,"about_ca_topic_score_gemma":0.002545189,"domain_scores_codex":[0.9989803,0.0003807796,0.0001806766,0.0002138789,0.00009179825,0.000152519],"domain_scores_gemma":[0.9989974,0.0003892352,0.0002597394,0.0001453911,0.00005950342,0.0001487412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9696018,0.0004568781,0.002714619,0.001579439,0.0141895,0.00005553645,0.00005144543,0.0003131208,0.00138471,0.00005468399,0.0004629671,0.009135298],"study_design_scores_gemma":[0.9390076,0.01935389,0.01458418,0.0001841432,0.02462289,0.0000824292,0.00007112783,0.0007007173,0.0004507962,0.0002859555,0.0006048905,0.00005132716],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9554992,0.03662214,0.001140793,0.0008508447,0.001111508,0.001113228,0.001815237,0.0001396946,0.001707465],"genre_scores_gemma":[0.990919,0.004304246,0.000539952,0.0008641089,0.0006691595,0.0007063132,0.001131818,0.00001934611,0.0008459772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006162418,"threshold_uncertainty_score":0.01432401,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01639903670994819,"score_gpt":0.2730839111137107,"score_spread":0.2566848744037625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}